Most edited pathways

Showing below up to 250 results starting with #251.

View (previous 250) (next 250) (20 | 50 | 100 | 250 | 500)

251. Homo sapiens:Nod-like receptor (NLR) signaling pathway ‎(37 revisions)
252. Homo sapiens:Endometrial cancer ‎(37 revisions)
253. Homo sapiens:Proteasome degradation ‎(36 revisions)
254. Homo sapiens:Growth factors and hormones in beta cell proliferation ‎(36 revisions)
255. Homo sapiens:Leukotriene metabolic pathway ‎(36 revisions)
256. Homo sapiens:Codeine and morphine metabolism ‎(36 revisions)
257. Homo sapiens:Nuclear receptors in lipid metabolism and toxicity ‎(36 revisions)
258. Homo sapiens:Downregulation of ACE2 by SARS-CoV-2 spike protein ‎(36 revisions)
259. Homo sapiens:DYRK1A involvement regarding cell proliferation in brain development ‎(36 revisions)
260. Homo sapiens:Biogenic amine synthesis ‎(36 revisions)
261. Homo sapiens:Cysteine and methionine catabolism ‎(36 revisions)
262. Homo sapiens:MAPK cascade ‎(36 revisions)
263. Homo sapiens:Alternative pathway of fetal androgen synthesis ‎(36 revisions)
264. Homo sapiens:Physico-chemical features and toxicity-associated pathways ‎(36 revisions)
265. Homo sapiens:Arylamine metabolism ‎(36 revisions)
266. Homo sapiens:Biotin metabolism, including IMDs ‎(35 revisions)
267. Mus musculus:Folic acid network ‎(35 revisions)
268. Homo sapiens:Sulfatase and aromatase pathway ‎(35 revisions)
269. Homo sapiens:Serotonin receptor 4/6/7 and NR3C signaling ‎(35 revisions)
270. Mus musculus:Regulation of cardiac hypertrophy by miR-208 ‎(35 revisions)
271. Homo sapiens:IL6 signaling pathway ‎(35 revisions)
272. Homo sapiens:Measles virus infection ‎(35 revisions)
273. Homo sapiens:Oxidative phosphorylation ‎(35 revisions)
274. Rattus norvegicus:p53 signal pathway ‎(35 revisions)
275. Gibberella zeae:DON mycotoxin biosynthesis ‎(35 revisions)
276. Rattus norvegicus:Cholesterol metabolism ‎(35 revisions)
277. Homo sapiens:DNA mismatch repair ‎(35 revisions)
278. Homo sapiens:TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) ‎(35 revisions)
279. Arabidopsis thaliana:Flowering time pathway ‎(35 revisions)
280. Homo sapiens:Hijack of ubiquitination by SARS-CoV-2 ‎(35 revisions)
281. Homo sapiens:Nicotine metabolism in liver cells ‎(35 revisions)
282. Homo sapiens:Heme biosynthesis ‎(35 revisions)
283. Mus musculus:Glycolysis and gluconeogenesis ‎(35 revisions)
284. Homo sapiens:G protein signaling pathways ‎(34 revisions)
285. Homo sapiens:Non-homologous end joining ‎(34 revisions)
286. Homo sapiens:Primary focal segmental glomerulosclerosis (FSGS) ‎(34 revisions)
287. Homo sapiens:Regulation of toll-like receptor signaling pathway ‎(34 revisions)
288. Mus musculus:Statin pathway ‎(34 revisions)
289. Homo sapiens:IL-7 signaling pathway ‎(34 revisions)
290. Mus musculus:GPCRs, other ‎(34 revisions)
291. Homo sapiens:IL-2 signaling pathway ‎(34 revisions)
292. Homo sapiens:7-oxo-C and 7-beta-HC pathways ‎(34 revisions)
293. Rattus norvegicus:Catecholamine synthesis ‎(34 revisions)
294. Homo sapiens:IL-4 signaling pathway ‎(34 revisions)
295. Homo sapiens:Aflatoxin B1 metabolism ‎(34 revisions)
296. Homo sapiens:Sulfation biotransformation reaction ‎(34 revisions)
297. Homo sapiens:Head and neck squamous cell carcinoma ‎(34 revisions)
298. Homo sapiens:Steroid biosynthesis ‎(34 revisions)
299. Homo sapiens:Eukaryotic transcription initiation ‎(34 revisions)
300. Homo sapiens:Pentose phosphate metabolism ‎(34 revisions)
301. Mus musculus:Calcium regulation in cardiac cells ‎(34 revisions)
302. Homo sapiens:Glycogen synthesis and degradation ‎(34 revisions)
303. Homo sapiens:SARS-CoV-2 innate immunity evasion and cell-specific immune response ‎(34 revisions)
304. Homo sapiens:T cell modulation in pancreatic cancer ‎(34 revisions)
305. Homo sapiens:Notch signaling ‎(34 revisions)
306. Homo sapiens:Apoptosis modulation by HSP70 ‎(33 revisions)
307. Mus musculus:Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling ‎(33 revisions)
308. Homo sapiens:Serine metabolism ‎(33 revisions)
309. Plasmodium falciparum:Isoprenoid precursor biosynthesis in Pf apicoplasts ‎(33 revisions)
310. Rattus norvegicus:VEGF-receptor signal transduction ‎(33 revisions)
311. Homo sapiens:Angiotensin II receptor type 1 pathway ‎(33 revisions)
312. Homo sapiens:Roles of ceramides in development of insulin resistance ‎(33 revisions)
313. Homo sapiens:Androgen receptor signaling pathway ‎(33 revisions)
314. Caenorhabditis elegans:Metapathway signal transduction ‎(33 revisions)
315. Homo sapiens:Cardiac progenitor differentiation ‎(33 revisions)
316. Saccharomyces cerevisiae:Phosphatidic acid and phospholipid biosynthesis ‎(33 revisions)
317. Homo sapiens:Nanoparticle triggered regulated necrosis ‎(33 revisions)
318. Mus musculus:Glutathione and one-carbon metabolism ‎(33 revisions)
319. Homo sapiens:Aerobic glycolysis - simplified ‎(33 revisions)
320. Mycobacterium tuberculosis:D-arginine and D-ornithine metabolism ‎(33 revisions)
321. Homo sapiens:EGF/EGFR signaling pathway ‎(33 revisions)
322. Homo sapiens:Affected pathways in Duchenne muscular dystrophy ‎(33 revisions)
323. Arabidopsis thaliana:Plant primary metabolism ‎(32 revisions)
324. Homo sapiens:AXL signaling pathway ‎(32 revisions)
325. Saccharomyces cerevisiae:High-osmolarity glycerol (HOG) pathway ‎(32 revisions)
326. Homo sapiens:Breast cancer pathway ‎(32 revisions)
327. Homo sapiens:Host-pathogen interaction of human coronaviruses - MAPK signaling ‎(32 revisions)
328. Homo sapiens:Glutathione metabolism ‎(32 revisions)
329. Mus musculus:Focal adhesion ‎(32 revisions)
330. Homo sapiens:Hypothesized pathways in pathogenesis of cardiovascular disease ‎(32 revisions)
331. Homo sapiens:Glucuronidation ‎(32 revisions)
332. Homo sapiens:Angiopoietin-like protein 8 regulatory pathway ‎(32 revisions)
333. Homo sapiens:RAS and bradykinin pathways in COVID-19 ‎(32 revisions)
334. Mus musculus:Microglia pathogen phagocytosis pathway ‎(32 revisions)
335. Homo sapiens:Cell-type dependent selectivity of CCK2R signaling ‎(32 revisions)
336. Saccharomyces cerevisiae:Glycolysis and gluconeogenesis ‎(32 revisions)
337. Zea mays:Vitamin B3 (niacin), NAD and NADP biosynthesis pathway ‎(32 revisions)
338. Homo sapiens:Ebola virus infection in host ‎(32 revisions)
339. Drosophila melanogaster:Fatty acid biosynthesis ‎(32 revisions)
340. Homo sapiens:Mitochondrial long chain fatty acid beta-oxidation ‎(32 revisions)
341. Homo sapiens:B cell receptor signaling pathway ‎(32 revisions)
342. Rattus norvegicus:ATM signaling pathway ‎(32 revisions)
343. Homo sapiens:Inflammatory response pathway ‎(31 revisions)
344. Homo sapiens:Endochondral ossification with skeletal dysplasias ‎(31 revisions)
345. Homo sapiens:Oligodendrocyte specification and differentiation, leading to myelin components for CNS ‎(31 revisions)
346. Mus musculus:GPCRs, class A rhodopsin-like ‎(31 revisions)
347. Homo sapiens:Formation of Fibrin Clot and the Clotting Cascade ‎(31 revisions)
348. Homo sapiens:Rett syndrome ‎(31 revisions)
349. Mus musculus:Electron transport chain ‎(31 revisions)
350. Homo sapiens:G13 signaling pathway ‎(31 revisions)
351. Homo sapiens:Corticotropin-releasing hormone signaling pathway ‎(31 revisions)
352. Homo sapiens:Gastric cancer network 2 ‎(31 revisions)
353. Homo sapiens:Cell cycle checkpoints ‎(31 revisions)
354. Gallus gallus:Toll-like receptor pathway ‎(31 revisions)
355. Anopheles gambiae:GPCR-Calcium ‎(31 revisions)
356. Caenorhabditis elegans:Crystal toxin triggered necrosis pathway ‎(31 revisions)
357. Homo sapiens:Endochondral ossification ‎(31 revisions)
358. Homo sapiens:3q29 copy number variation syndrome ‎(31 revisions)
359. Mus musculus:Selenium micronutrient network ‎(31 revisions)
360. Homo sapiens:MET in type 1 papillary renal cell carcinoma ‎(31 revisions)
361. Mus musculus:Serotonin and anxiety-related events ‎(30 revisions)
362. Rattus norvegicus:Pentose phosphate pathway ‎(30 revisions)
363. Homo sapiens:Thiamine metabolic pathways ‎(30 revisions)
364. Saccharomyces cerevisiae:Crabtree effect ‎(30 revisions)
365. Homo sapiens:Alpha 6 beta 4 signaling pathway ‎(30 revisions)
366. Homo sapiens:Notch signaling pathway ‎(30 revisions)
367. Saccharomyces cerevisiae:TCA cycle ‎(30 revisions)
368. Anopheles gambiae:testing testing ‎(30 revisions)
369. Mus musculus:Tyrobp causal network in microglia ‎(30 revisions)
370. Homo sapiens:Small ligand GPCRs ‎(30 revisions)
371. Homo sapiens:Prostaglandin signaling ‎(30 revisions)
372. Homo sapiens:Glial cell differentiation ‎(30 revisions)
373. Mus musculus:Tryptophan metabolism ‎(30 revisions)
374. Zea mays:Vitamin B5 (pantothenate) and CoA biosynthesis Pathway ‎(30 revisions)
375. Mus musculus:Glucocorticoid and mineralcorticoid metabolism ‎(30 revisions)
376. Homo sapiens:Urea cycle and metabolism of amino groups ‎(30 revisions)
377. Homo sapiens:Flavan-3-ol metabolic pathway ‎(30 revisions)
378. Oryza sativa:Seed development ‎(30 revisions)
379. Homo sapiens:Dravet syndrome ‎(30 revisions)
380. Drosophila melanogaster:Toll, IMD, JAK/STAT pathways for immune response to pathogens ‎(30 revisions)
381. Homo sapiens:EGFR tyrosine kinase inhibitor resistance ‎(30 revisions)
382. Homo sapiens:NRP1-triggered signaling pathways in pancreatic cancer ‎(30 revisions)
383. Homo sapiens:GPCRs, other ‎(29 revisions)
384. Saccharomyces cerevisiae:MAPK signaling pathway ‎(29 revisions)
385. Homo sapiens:Cholesterol biosynthesis ‎(29 revisions)
386. Homo sapiens:Proline and hydroxyproline pathways ‎(29 revisions)
387. Zea mays:Vitamin B9 (folate) biosynthesis pathway ‎(29 revisions)
388. Homo sapiens:Mineralocorticoid biosynthesis ‎(29 revisions)
389. Homo sapiens:Phase I biotransformations, non-P450 ‎(29 revisions)
390. Rattus norvegicus:Thick ascending limb transporters ‎(29 revisions)
391. Homo sapiens:Major receptors targeted by epinephrine and norepinephrine ‎(29 revisions)
392. Homo sapiens:16p11.2 proximal deletion syndrome ‎(29 revisions)
393. Rattus norvegicus:Electron transport chain ‎(29 revisions)
394. Rattus norvegicus:Angiotensin II signaling (acute) in thick ascending limbs ‎(29 revisions)
395. Homo sapiens:Familial partial lipodystrophy ‎(29 revisions)
396. Oryza sativa:Octadecanoid pathway ‎(29 revisions)
397. Danio rerio:Nodal signaling pathway ‎(29 revisions)
398. Mus musculus:Mecp2 and associated Rett syndrome ‎(29 revisions)
399. Homo sapiens:Dopamine metabolism ‎(29 revisions)
400. Homo sapiens:Hedgehog signaling pathway ‎(29 revisions)
401. Homo sapiens:Pilocytic astrocytoma ‎(29 revisions)
402. Homo sapiens:Hepatocyte growth factor receptor signaling ‎(29 revisions)
403. Homo sapiens:SARS-CoV-2 and ACE2 receptor: molecular mechanisms ‎(29 revisions)
404. Homo sapiens:Molybdenum cofactor (Moco) biosynthesis ‎(29 revisions)
405. Homo sapiens:FGFR3 signaling in chondrocyte proliferation and terminal differentiation ‎(29 revisions)
406. Homo sapiens:CAMKK2 pathway ‎(29 revisions)
407. Saccharomyces cerevisiae:Glucose repression ‎(29 revisions)
408. Homo sapiens:PI3K/AKT/mTOR - vitamin D3 signaling ‎(29 revisions)
409. Mus musculus:Myometrial relaxation and contraction pathways ‎(29 revisions)
410. Rattus norvegicus:Wnt myofibroblastic activation of hepatic stellate cells ‎(28 revisions)
411. Rattus norvegicus:Folic acid network ‎(28 revisions)
412. Saccharomyces cerevisiae:Glucose-1-phosphate metabolism ‎(28 revisions)
413. Homo sapiens:Response to elevated platelet cytosolic Ca ions ‎(28 revisions)
414. Homo sapiens:NAD metabolism, sirtuins and aging ‎(28 revisions)
415. Homo sapiens:Thyroid hormones production and peripheral downstream signaling effects ‎(28 revisions)
416. Mus musculus:Primary focal segmental glomerulosclerosis (FSGS) ‎(28 revisions)
417. Homo sapiens:IL-17 signaling pathway ‎(28 revisions)
418. Mus musculus:Deregulation of renin-angiotensin system by SARS-CoV infection ‎(28 revisions)
419. Homo sapiens:Clear cell renal cell carcinoma pathways ‎(28 revisions)
420. Homo sapiens:TCA cycle nutrient use and invasiveness of ovarian cancer ‎(28 revisions)
421. Caenorhabditis elegans:TCA cycle ‎(28 revisions)
422. Homo sapiens:Amino acid conjugation of benzoic acid ‎(28 revisions)
423. Homo sapiens:p38 MAPK signaling pathway ‎(28 revisions)
424. Homo sapiens:Vitamin D receptor pathway ‎(28 revisions)
425. Arabidopsis thaliana:2-acetyl-1-pyrroline pathway ‎(28 revisions)
426. Homo sapiens:IL-5 signaling pathway ‎(28 revisions)
427. Mus musculus:Dopaminergic neurogenesis ‎(28 revisions)
428. Homo sapiens:PI3K-AKT-mTOR signaling and therapeutic opportunities in prostate cancer ‎(28 revisions)
429. Escherichia coli:Escherichia coli K-12 peripherome ‎(28 revisions)
430. Homo sapiens:Calcium mediated T-cell apoptosis involved in inclusion body myositis ‎(28 revisions)
431. Homo sapiens:Hair follicle development: induction - stage 1 of 3 ‎(28 revisions)
432. Mus musculus:Wnt signaling in kidney disease ‎(28 revisions)
433. Homo sapiens:Non-small cell lung cancer ‎(28 revisions)
434. Caenorhabditis elegans:Cell engulfment ‎(28 revisions)
435. Homo sapiens:Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway ‎(28 revisions)
436. Rattus norvegicus:NFE2L2 ‎(28 revisions)
437. Homo sapiens:Cell interactions of the pancreatic cancer microenvironment ‎(28 revisions)
438. Homo sapiens:Pyrimidine metabolism ‎(28 revisions)
439. Homo sapiens:IL-9 signaling pathway ‎(28 revisions)
440. Homo sapiens:Parkin-ubiquitin proteasomal system pathway ‎(28 revisions)
441. Homo sapiens:Nucleotide metabolism ‎(28 revisions)
442. Homo sapiens:Aryl hydrocarbon receptor pathway ‎(28 revisions)
443. Homo sapiens:S1P receptor signal transduction ‎(28 revisions)
444. Homo sapiens:Serotonin receptor 2 and ELK-SRF/GATA4 signaling ‎(28 revisions)
445. Homo sapiens:Transport of glycerol from adipocytes to liver by aquaporins ‎(28 revisions)
446. Homo sapiens:4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression ‎(28 revisions)
447. Mus musculus:Purine metabolism ‎(27 revisions)
448. Rattus norvegicus:Glucocorticoid effect on target gene expression ‎(27 revisions)
449. Homo sapiens:Alstrom syndrome ‎(27 revisions)
450. Homo sapiens:RANKL/RANK signaling pathway ‎(27 revisions)
451. Mus musculus:Chemokine signaling pathway ‎(27 revisions)
452. Homo sapiens:Benzo(a)pyrene metabolism ‎(27 revisions)
453. Homo sapiens:Folate-alcohol and cancer pathway hypotheses ‎(27 revisions)
454. Homo sapiens:Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins ‎(27 revisions)
455. Bos taurus:Folate metabolism ‎(27 revisions)
456. Mycobacterium tuberculosis:Lipoic acid metabolism ‎(27 revisions)
457. Homo sapiens:Polyol pathway ‎(27 revisions)
458. Homo sapiens:Integrin-mediated cell adhesion ‎(27 revisions)
459. Arabidopsis thaliana:Kaempferol derivatives ‎(27 revisions)
460. Homo sapiens:Amino acid transport defects (IEMs) ‎(27 revisions)
461. Homo sapiens:Ulcerative colitis signaling ‎(27 revisions)
462. Homo sapiens:Mitochondrial beta-oxidation ‎(27 revisions)
463. Mus musculus:Focal adhesion: PI3K-Akt-mTOR signaling pathway ‎(27 revisions)
464. Homo sapiens:Carnosine metabolism of glial cells ‎(27 revisions)
465. Danio rerio:TCA cycle ‎(27 revisions)
466. Homo sapiens:Cannabinoid receptor signaling ‎(27 revisions)
467. Mus musculus:Mapk signaling pathway ‎(27 revisions)
468. Homo sapiens:Ganglio sphingolipid metabolism ‎(27 revisions)
469. Homo sapiens:Lactate shuttle in glial cells ‎(27 revisions)
470. Homo sapiens:Eukaryotic translation initiation ‎(27 revisions)
471. Homo sapiens:Common pathways underlying drug addiction ‎(27 revisions)
472. Homo sapiens:Post-translational modification: synthesis of GPI-anchored proteins ‎(27 revisions)
473. Homo sapiens:Sphingolipid metabolism in senescence ‎(27 revisions)
474. Homo sapiens:Opioid signaling ‎(27 revisions)
475. Homo sapiens:SRF and miRs in smooth muscle differentiation and proliferation ‎(27 revisions)
476. Homo sapiens:Focal adhesion: PI3K-Akt-mTOR-signaling pathway ‎(27 revisions)
477. Homo sapiens:Epigallocatechin-3-O-gallate / epigallocatechin / epicatechin breakdown pathway ‎(26 revisions)
478. Danio rerio:BMP signaling pathway ‎(26 revisions)
479. Rattus norvegicus:Triacylglyceride synthesis ‎(26 revisions)
480. Homo sapiens:Pluripotent stem cell differentiation pathway ‎(26 revisions)
481. Homo sapiens:GNAQ pathways in port-wine stain ‎(26 revisions)
482. Homo sapiens:Activation of gene expression by SREBF (SREBP) ‎(26 revisions)
483. Homo sapiens:Regulation of apoptosis by parathyroid hormone-related protein ‎(26 revisions)
484. Rattus norvegicus:Irinotecan pathway ‎(26 revisions)
485. Mus musculus:Adar1 editing defficiency immune response ‎(26 revisions)
486. Homo sapiens:Nephrotoxcicity adverse outcome pathway ‎(26 revisions)
487. Homo sapiens:Steroid hormone precursor biosynthesis ‎(26 revisions)
488. Homo sapiens:Integration of energy metabolism ‎(26 revisions)
489. Homo sapiens:Ras signaling ‎(26 revisions)
490. Homo sapiens:miR-targeted genes in leukocytes ‎(26 revisions)
491. Mus musculus:FAS pathway and stress induction of HSP regulation ‎(26 revisions)
492. Homo sapiens:Copper homeostasis ‎(26 revisions)
493. Homo sapiens:Copper metabolism ‎(26 revisions)
494. Homo sapiens:Apoptotic execution phase ‎(26 revisions)
495. Homo sapiens:Exercise-induced circadian regulation ‎(26 revisions)
496. Homo sapiens:MicroRNAs in cardiomyocyte hypertrophy 2 ‎(26 revisions)
497. Homo sapiens:Pathways affected in adenoid cystic carcinoma ‎(26 revisions)
498. Mus musculus:Eicosanoid metabolism via lipoxygenases (LOX) ‎(26 revisions)

View (previous 250) (next 250) (20 | 50 | 100 | 250 | 500)